Michael After our time. review looking a and be everyone. our turn results. I'll already summary the joined many to current for call I to a Having morning, that, detailed executive this proven has valuable markets good the in performance. business more for new to our few our forward the the an first the know a are our and of finance Russell, position excellent that of hearing on QX organization I'll of in team. CFO, over company with Michael our from Turner, third September, Michael Thanks, open morning a climate, comments to addition you of quarter and leader
Michael. aboard, welcome So
year-to-date, backdrop supply Reflecting the by chain the on economic compounded and the has COVID disruptions existing global pandemic. created geopolitical
macro these and investment manufacturing news in our the in This their reduce that order production costs. customers environment. for adopting is industry more many an impacting increasingly growth good are companies, are even manufacturing While product in chain enhance supply for opportunity cautious to negatively flexibility design headwinds additive capital gives us operations risks, a reduce
prior to Systems already and the platforms For showing efficiency allowed XD our efforts this investments in streamline our sheet. results. which initiatives, focus operational in balance company make from while and significantly us specifically, technology year strengthening new has we benefited to important are This
industry than refreshed our execution, this scale needed support stronger Our we're customers meantime, are our an once confident ever on leader. expect In subside, emerge product profitability the recession we which will customers efficient fears performance, to and footprint their and focusing with operational period a lineup completely and intently from that is cash shareholders what and from the growth.
future. the we of we're that dedicated tell the of behalf world, the X,XXX the and leadership On proud year about Systems nearly our ahead can you XXXX, as very finished my role around I colleagues industry to XD look in and confident out additive
a costs. performance. pricing lag labor both impacting possible, quarterly drag line that we quarter, an is to operating internal offset on them. pressures, basically Turning purchase taking We're actions, and that our these to areas, effect exceeded Slide expectations and, then where a delivered put but there's components Reflecting standpoint, with in in results X. were inflation typically From high can some our third on
factors these Michael performance. U.S. the of light strength moments. in a dollars will few clearly impacted financial addition, our shed the on In more
the chains this trend further disruptions continue. showing On initial occur, And no of signs if to we expect side, positive supply are stabilization.
hard engineers supply to sourcing to component Our worked more increase in base new our have options and mind. products design with our
our the to Hill, plant I'm progress over manufacturing, of in contract in-sourcing facility, manufacturer. our from we Rock our pleased made with very printing of polymer we've production which over produce mid-quarter a regard South With soon will took This Carolina systems. XX%
to people in our momentum. percentage that investments expect We technology grow gain as and rapidly
and a colleagues were begin transition to In sincere expand margins pleased as Carolina. production to quarter, manufacturing the Systems our our increase, to to out improve we XD South shout management. want see in new to third the our give our rates productivity workforce gross I
Your efforts are noticed and greatly appreciated.
is standpoint, global upon a toll discretionary inflation consumer that From a dependent spending. significant markets on broader taking are
daily more they like have spend spend items. on less gasoline, and to on consumers As necessities food optional
this our impacts us, our markets and products. For orthodontic dental particularly,
be While seen slowed this have in spending, anticipated customers is financials. business we're committed that clearly their can our still in guidance, while a fully key to, our previous great which, largely
once business normalizes, the take some this strengthen expect we to economy Fortunately, this time. but may
to market business of a few and understanding give our how works in model on this a dynamics More in clear but want in now, position for come to you our I volatile our industry climate. moments, the
across and all The reasons additive manufacturing twofold. widespread, As positioned well we're to becomes market environments enable adoption are very virtually production rapid verticals.
complex the the the combined, is greater the our of integration in industry world. the of on. experience active our unparalleled day than every of produce rest proprietary customers have in our technology. in management using tons This output of over we factories and field, million experience fleets the almost us year, base XX,XXX greatest of X,XXX draw parts to each around With large production workflows consuming over giving entire materials the customers' our printers X printers First, in
reorganized applications, This additional highly proven we units, then growth for effective, us in the over complete, exciting the are the and their on effective to workflows factories. added approach then and and years, most the Once and growth to manufacturing has restructured market-facing enables expanded capacity and X.X will into we've their customers company drive Healthcare into last believe with years Second, of business focus these transfer company ahead. manufacturing Solutions our technologies market-specific our it developing our plans. supporting Solutions. workflows support This X Industrial
This our is It full sets the is operational having for around increasingly materials. partner. that is competition, of our that model are address gap of key and others of metal to and software the complement and what to looking company a a a see mimicked specific apart to applications, production continues That this printing the these elements, by grow. supported combination high-value in success customers from industry, our we expertise wide is one range by but polymer technologies
core systems broadest the the broadly metal truly unique of Systems, materials and of polymer I in Today, our span, printing also technology drug the and for printing and industry, at now only not materials that the refer development. XD methodologies but include range in body groundbreaking development essential These biologics. to are addressing in and human the technologies new biological within as applications systems
total, now in application production unique company to viewed a enter allows technologies of in with as us additive position scale this environments. expertise true and assume industry we global combination in leadership When the a
turn quarter. for now I'll the introduction, a of overview that X brief Slide to With
year-over-year. during XXXX, decreased consolidated adjusting company, X.X% we revenue for that after the third the businesses For divested for quarter
strong increased foreign currency significant impact U.S. adjusting the for showing revenue fluctuations, of the dollar. negative consolidated However, of the X.X%, impact
like, double-digit meet long-term all lower this much rate as manufacturing than segments. we of would ahead, expectations growth takes years in rebounds growth market fully expect to our consumer environments and we While hold virtually in organic spending production additive is the across
X% constant substantial third due by quarter. slowing in the to for year divestiture-adjusted in decreased our flat our Dental constant and segment softer in was X.X% driven our segment Solutions Revenue Solutions of increased performance nearly segment a but Healthcare X.X% Turning decreased our Revenue consumer Industrial spending. currency, segment to currency. for per year-over-year
to Industrial due Healthcare was last FX As impact said, service sales to segment's bureau Asia also Solutions on the our Europe With in segment pronounced and and on material. impact we saw exposure that the was that customers Solutions quarter, currency Pacific. manufacturers most
in given historically we recession market in and Europe, third In pressure in Industrial our and our Ukraine segment's in Industrial impactful Europe our customers. to supplies particularly, regarding Germany. strong variations uncertainty energy Solutions is presence business, quarter. In the continue and regional the Solutions This war saw
side, Americas strong sales positive verticals. third during quarter printer and the robust in the SLA with the remained commercial space On demand and the into energy
for solid recently Titan saw among and also defense our demand platform goods acquired We consumer printer customers.
sales quarter doctors, holding the business, and business growth strong years other experience system despite of health up In Medical for planning varied of virtual our the sharply manufacturing who to broader And care in The significant customers business, Within well. as manufacture for industry-leading outcomes. improve year-over-year best-in-class nonelective performance quarter to strong by uncertainty. a strong surgical Healthcare out our is story our demand additive surgeons Solutions market, personalized is for surgical had infrastructure regulatory packages and orthopedic solutions instrumentation. solutions our using third procedures economic printer we In and surgical patient products, that here stands market. saw XD suite of and providing Devices hospitals well
Solutions the in market area. year-over-year factor sales, dental decline the However, biggest the particularly in orthodontic was business for our during Healthcare quarter significant a
it's this our were difficult for how with dependent on so coming. was expectations. might evolve to our It's how that roughly conditions As third disappointing, last And line last were we demand quarter, in softer coming investors gauge results over because we decline while this quarters. quarter, communicated long general the macroeconomic our aware the to
strong this business growth to recover and to a and contributor eventually be profitability. We our expect to
ups guidance expenses for good of tighten in This remainder improving we Michael forecast and strong controls. reflect will XXXX the for performance these and broad this updating to full is our we're despite the execution into year cost moment, downs, you have for now describe significantly believe revenue as our while our why, a operating So business to range we visibility year.
valuable to advancements the only in quarter. to Slide they but These insights are core highlight activities like X. in will our I'd from of interesting provide third X next the company's not the that growth also isolation, type years. Turning drive into some
agreed As developer third I designed components. true of the quarter the for industry's quarter's mass described production polar, Germany-based acquire call, for manufacturing to last you system on we first the our dp of additive during customized high-speed
platform bringing can't The the this a up that of of process print efforts ahead leap early quantum represents and portfolio. build October, we rotating are enough closed custom systems, jetted of pleased production mass componentry true the than in additive report technology today's acquisition I'm faster this manufacturing. I machine's XD schedule, revolutionary to into toward to well printer batch Systems importance parts polymer underway. emphasize can which integration continuously Xx using
If XXXX. for with machines testing moving XXXX as customers polar are mass system you dp fast any initial the visit Trade I We strongly polar in move commercial yourself. and booth Show technology Form for be sales at this possible you planning as targeted in into plan Next exciting November, of dp of forward encourage key see to to to critical a upcoming new beta with the this with and
applications we lineup strong With our with health portfolio, customers our segments. leverage metal to of metal solution both to capabilities continue care the innovation drive printing industrial sales group, along unique in technologies, and of to our printing
the specialized. alloys. Our is best such We've titanium, space suited successful printing technology which very long advantage and type extremely in medical are well refractory primarily reactive solutions technological the as and of devices, recently metals in with commercial customer-specific of Systems the customers is and which both metal nickel for our manufacture control which system, atmosphere application-focused our industry's is XD been of to in
third several significant announced additions quarter, to our we portfolio. Materials also the During
On of SLS printing X verticals. for projection-based customers and printer our tough introduced applications for DuraForm across platforms, Black market Both we several with these X clear materials, production-grade side, the materials critical address polymer Figure line. new Pax key
its certified United shipbuilding On the particularly Newport nickel can highly developed XD News to close all high DMP with in which print to States. new This alloy, the on printing metal be in now XX], Shipbuilding, solutions. largest we [CuNI metals which is copper and front, nickel is Industries of introduced Huntington reflectivity. company our collaboration a challenging Copper Ingalls the of division use is due was copper alloy for
gas; However, for material and rocketry. and oil it's extremely systems; marine an applications of demanding in chemical course, ideal processing plants;
business. for highlight hand to X, one making before and the namely progress most to Slide my a to we're goals world-class tremendous Michael, important on creation want medicine Turning I I of Systems, of the XD regenerative off
kidneys. human our proceeding shared printing organs and now partnership efforts for this I've goal As X in currently toward through livers with previously, lungs, XD functional our of We've Therapeutics. scope, including achieved an targeting a along primary with are biotechnology you lines: but progress partner, first, expanded transplantation, our United remarkable with long-standing area initially
Our goal to trials and have partner within years. is summer organs this announced printed that our human publicly X
organ Second, of reconstruction tissue the printing and the More field this the transplantation months progress, initiative building ahead. on into technological adjacent announced surgical we've in details be human expanded exciting program's applications. regarding non-organ for will
But the combining is in polymer on case, today, with on on third summarized for I pharmaceutical this highly and focus and manufacture capability our industry. X. drug Chart the this expertise we're discovery development by organs tissue our to human leveraging vascularized initiative, to want chips which In and printing develop use in differentiated expertise creating
managed new an with R&D biotech of a in company this During the wholly-owned This formation is as an our company and Bio. being to of milestone should million, sustain marked third a reaches investment it until staff. initiative committed seed quarter, startup revenue Systemic major $XX team and internal of of we called profitability. management Bio with announcement dedicated a own the initial subsidiary Systemic We've material level the with support which its
human those Bio One traditional themselves model. customers business with materials, biotech pharmaceutical drug sell and point go-to-market value chips we'll platform, engaged Due to chips, printers the to unique work organs it market directly to and that strategy rather models Bio's develop of will Systemic and disease-specific organ not will for companies and want in printed is on and to this discovery. then that XD sensitivity the will from technology of emphasize products Systemic differ novel Systems' the I
for combination components disease the are vascular model, or with XD call comprised is human Systemic these scaffolds This patent-print integrated microfluidic Bio healthy seeded Once we platform support has studies. custom-designed a invented then which HVIOS. scaffolds. vascularized system. desired This drug pending novel stands cell and Houston To business vascularized for organ-on-a-chip printed, any organ types of bioprinted platform of XD-printed
where systemic chips in HVIOS producing collaboration functions being use of organ they're state-of-the-art key by validate to laboratory our tested We're at daily our Houston, disease team their in specific modeling scientists Texas, with for bios customers. pharma and
can any develop see produced then virtually and studies. data be on images the desired for statistical architecture you As can mass X, the printed in to vasculature needed Slide drug
X. Slide to Turning
new fully HVIOS organ within -- Let works throw the me within Bio's technological waste The from implanted therefore, Systemic closely vasculature structure. we're tissue left see sample, lower XD business. contained active emphasize allowing perfusion products flow why through what the approach -- can printed about cell flow image, today as for to is blood where process then shown the market in body. bring bioprinted and structures, those blood differentiates excited remove to integrated human this in Bio's of chip the XD cells so needed as blood vasculature mimic Systemic is the can survival nutrients your the just for This through the as within you critical and
right-hand for with this the HVOIS regions on the in the the image tissue success and days. in over unique, tissues this Slide these see is the have This human printed cells green that it's being type. The of magic be comprising lower any system. thrived true of cell can sample approach can types You XX of X,
them example, together the circuit. of with connecting the and vessels liver human continuous For on be in can other can the printed end blood on cells, chip be cancer a cells one and
the of high with create the blood any drugs in an Developmental then volumes. ability be with environment evaluate healthy virtually continuous introduced cells interaction can tissues to cells a cancer at and flow combination the both to
shortened, eliminated can time. of over and animal success believe that For drug the enhanced rates ultimately we development using evaluation testing cycle be use the this technology,
early to standpoint, of affirm over say, see this contracts excited drug goal key a customer to companies with industry development is into From the business, technology it establish the and next pharmaceutical potential technology. year of to the financial driving validation I'm about incorporate to I'm new our our the Needless tremendously and protocols.
printing should company HVIOS note and given be the business a Based a highly confident believe has potential X Bio, bioprinting million agreement to pharmaceutical years. could advanced Systemic you. and technology, profit than company its supplier. manufacturing in company progress and Bio we'll feedback, first model revenue our upon I that capabilities technology a major within near forward future, announce rather believe proprietary, we of margins the early than I'm customer like to look in Systemic a company $XXX Investors biotech more with chips biomaterial selling that sharing achieve the the we with its
our remarks highlight Geomagic, XXXX Systems been XD Before solutions to provider digital applications to XD automate an over utilize to software, as significantly position XD offering that Sprint in like by has business. of specialized turning and to machine such Michael, I late acquiring printing help XX by and production turn AI I'd XD intelligently learning innovator Experts. my software in the Slide leading to We to entire close long a software workflows. Oqton, advanced manufacturers their call
we've Slide on The offering action most control cloud-based XD are Since and that floor go-to-market factory transformed across by management legacy manufacturing agnostic result OS. end-to-end additive multiple It And acquisition operations delivery. order digital sites technology the entire of XX. manufacturing under Oqton integrating workflow shown of today, able Oqton. complete industry Systems structure manufacturing will hardware our provides, entire The digital being is the solution software the All and thread combined that neutral. a we're single XD software system be feature-rich stand-alone will Oqton, traceability as into the be software applications that seamlessly Oqton from software the to strategy. a the the now integrate of complete comparison and suite in and with of every provides in complete table to far, in
that each approach. called this point for offers. field put add solutions time through have automation. alternative at investments a manufacturers leading suppliers the customers DIY, the And to given in to equipment are of or the with players over complexity hesitant only they're middle and themselves an and shown spectrum fraction approach can column approach Oqton XD the both through While partnerships do-it-yourself, feature, the R&D the will together offering only in who, cost industrial do and or the capability Oqton to to of best, commercial other The commonly of we CAD continue leading so refine
integrated example with that would partnership road true in of of development development to not make joint importantly, industry. functionality partners As only include applications an that discussions new e-commerce a it major just Oqton the potential the identification, serial has of manufacturing become map, one on cataloging. suite new leads industry, manufacturing our part additive optimism Most scale enabler entire key the can our of impact software and
data, in software all very ranging this For platform. run digits, on platform, excited Oqton elements from To markets. this has the reason, automotive, This industry. and entire the operation to With and including firewalls to we wins acceptance the opened we dental triple of a every will now a about on security contract impact have industry-wide the additive of the to additive Oqton confidentiality. facilitate audited Oqton's and includes approach, XD growth future With the double potential of adoption, priority is gaining high sensitive as business have of this with manufacturing care Systems customer traction externally protection printing software, health is new aerospace, including manufacturing, we're user ensure day it availability historical the manufacturing as broadly. tremendous Oqton believe a stand-alone
review Michael I'd over third results. the And to quarter Michael? to call with that, financial like turn to our